1. Adair FE.
Treatment of melanoma: report of four hundred cases.
Surgery Gynecology Obstetrics 1936; 62: 406-419
2. Ang KK, Byers RM, Peters LJ, et al.
Regional Radiotherapy as adjuvant treatment for head and neck malignant melanoma. Archieves of Otolaryngology Head Neck Surgery 1990; 116: 169-172
3. Ang KK, Peters LJ, Weber RS, et al.
Postoperative radiotherapy for cutaneus melanoma of the head and neck region.
International Journal of Radiation Oncology Biol Phys 1994 ;30: 795-798
4. Balch CM, Soong SJ, Murad T, et al.
A multifactorial analysis of Melanoma. III. Prognostic factors in melanoma patientes with lymph node metastases ( Stage III).
Annals of Surgery 1981; 193: 377-388
5. Barranco SC, Romsdahl MM, Humphrey RM.
The radiation response of human malignant melanoma cells grown in vitro.
Cancer Research 1971; 31: 830-833
6. Bentzen SM, Overgaard J, Thames HD, et al.
Clinical radiobiology of malignant melanoma.
Radiotherapy and Oncology 1989; 16: 169-182
7. Bowsher WG, Taylor BA, Hughes LE.
Morbility, mortality, and local recurrence following regional node dissection for melanoma.
British Journal of Surgery 1986; 73: 906-908
8. Braun- Falco O, Plewig G, Wolff HH.
Dermatologie und Venerologie; Kapitel: Maligne Melanome . 4. Auflage, Springer-Verlag Berlin Heidelberg New York, 1996
9. Burmeister BH, Rad FF, Smithers BM, Poulsen M, et al.
Radiation therapy for nodal disease in malignant melanoma.
World Journal of Surgery 1995; 19: 369-371
10. Byers RM, et al.
The role of modified neck dissection in the treatment of cutaneous melanoma of the head and neck.
Archives of Surgery 1986; 121:1338-1341
11. Calabro A, Singletary SE, Balch CM.
Patterns of relapse in 1001 consecutive patients with melanoma nodal metastasis.
Archives of Surgery 1989; 124: 1051-1055
12. Callery C, Cochran AJ, Roe DJ, et al.
Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes.
Annals of Surgery 1982; 196: 69-75
13. Cascinelli N, Vaglini M, Nava M, et al.
Prognosis of skin melanoma with regional node metastasis (stage 2).
Journal of Surgical Oncology 1984; 25: 240-247
14. Choi KM, Withers HR, Rotman M.
Intracranial metastases from melanoma. Clinical features and treatment by accelerated fractionation.
Cancer 1985; 56: 1
15. Clark WH Jr, From L, Bernardino EA, Mihim MC.
The histogenesis and biologic behavior of primary human malignant melanomas of the skin.
Cancer Research 1969; 29: 705-726
16. Cochran AJ.
Malignant melanoma. 10 years´ experience in Glasgow, Scotland.
Cancer 1969; 23: 1190-1199
17. Cohen MH, Ketcham AS, et al.
Prognostic factors in patients undergoing lymphadenectomy for malignant melanoma.
Annals of Surgery 1977; 186: 635-642
18. Cooper JS, Carella R.
Radiotherapy of intracerebral metastatic malignant melanoma.
Radiology 1980; 134: 735-738
19. Corry J, Smith JG, Bishop M, et al.
Nodal radiation therapy für metastatic melanoma.
International Journal of Radiation Oncology Biol Phys. 1999; 44: 1065-1069
20. Creagan ET, Cupps RE, Ivins JC, et al.
Adjuvant radiation therapy for regional nodal metastases from malignant melanoma:
a randomized prospective study.
Cancer 1978; 42: 2206- 2210
21. Das Grupta TK.
Results of treatment of 269 patients with primary cutaneous melanoma: A 5-year prospective study.
Annals of Surgery 1977; 186: 201-209
22. Day CL Jr, Sober AJ, Lew RA, et al.
Malignant melanoma patients with positive nodes and relativly good prognosis.
Cancer 1981; 47: 955-962
23. Fenig E, Eidelevich E, Njuguna E, et al.
Role of radiation therapy in the management of cutaneous melanoma . American Journal of Clinical Oncology 1999; 22: 184-186
24. Fortner JG, Woodruff J, Schottenfeld D, MacLean B.
Biostatical basis of elektive node dissection for malignant melanoma.
Annals of Surgery 1977; 186: 101-103
25. Fortner JG, Booker RF, Pack GT.
Results of groin dissection for malignant melanoma in 220 patients.
Surgery 1964 ; 55: 485-495
26. Grob JJ, Dreno B, Salmoniere P, et al.
Randomised trial of interferon alfa-2a as adjuvant therapy in resected primary melanoma thicker than 1,5 mm without clinically detectable node metastases.
The Lancet 1998; 351; 1905-1910
27. Hansson J., Johansson H., Ringborg U.
Postoperative radiotherapy following surgery for regional lymph node metastasis in malignant melanoma: Proceedings of the Third International Conference on melanoma. Melanoma Research 1993; 3: 90
28. Harwood AR.
Conventional fractionated radiotherapy for 51 patients with lentigo maligna and lentigo maligna melanoma.
International Journal of Radiation Oncology Biol and Phys 1983; 9; 1019-1021
29. Hauschild A, Dummer R, Garbe C, et al.
Adjuvante Interferon Alfa Therapie beim Melanom.
Der Hautarzt 1998; 49: 167-169
30. Hornsey S.
The relationship between total dose, number of fractions and fraction size in the response of malignant melanoma in patients.
British Journal of Radiology 1978; 51: 905-909
31. Hornsey S.
The radiosensitivity of melanoma cells in culture . British Journal of Radiology 1972; 45: 158-160
32. Hornsey S.
The radiation response of human malignant melanoma cells in vitro and in vivo.
Cancer Research 1972; 32: 650-651
33. Johanson CR., Harwood AR, Cummings BJ, Quirt I.
Radiotherapy in nodular melanoma.
Cancer 1983; 51: 226-232
34. Karakousis CP, Seediq MK, Moore R.
Prognostic value of lymph node dissection in malignant melanoma.
Archives of Surgery 1980; 115: 719-722
35. Katz HP.
The results of different fractionation schemes in the palliative irradiation of metastatic melanoma.
International Journal of Radiation Oncology Biol Phys 1981; 7: 907
36. Kirkwood JM, Strawderman MH, Ernstoff MS, et al.
Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the eastern cooperative oncology group trial EST 1684.
Journal of Clinical Oncology 1996; 14: 7-17
37. Kiss B.
Large dose per fraction irradiation in the treatment of melanoma.
Melanoma Research 1993; 3: 91
38. Konefal JB, Emami B, Pilepich MV.
Analysis of dose fractination in the palliation of metastases from malignant melanoma. Cancer 1988; 61: 243-246
39. Lee RJ, Gibbs JF, Proulx GM, et al.
Nodal basin recurrences following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
International Journal of Radiation Oncology Biol Phys 2000; 46: 467-474
40. Miller EJ, Synnertvedt M, Schultz D, et al.
Locoregional nodal relapse in melanoma.
Surgery and Oncology 1992; 1: 333
41. Monsour PD, Sause WT, Avent JM, et al.
Local control following therapeutic nodal dissection for melanoma.
Journal of Surgical Oncology 1993; 54: 18-22
42. O´Brien CJ, Gianoutsos MP, Morgan MJ.
Neck dissection for cutaneous malignant melanoma.
World Journal of Surgery 1992; 16; 222-226
43. O´Brien CJ, Petersen-Schaefer K, Ruark D, et al.
Radical, modified, and selective neck dissection for cutaneous malignant melanoma.
Head Neck 1995; 17: 232-241
44. Overgaard J.
Radiation treatment of malignant melanoma.
International Journal of Radiation Oncology Biol Phys 1980; 6: 41-44
45. Overgaard J.
The role of radiotherapy in recurrent and metastatic malignant melanoma.
International Journal of Radiation Oncology Biol Phys 1986; 12: 867-872
46. Overgaard J.
The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study.
International Journal of Radiation Oncology Biol Phys 1986; 12: 867-872
47. Sause WT, Cooper JS, Rush S, et al.
Fraction size in external beam radiation therapy in the treatment of melanoma.
International Journal of Radiation Biol Phys 1991; 20: 429-432
48. Seegenschmiedt MH, Keilholz L, Altendorf-Hofmann A, et al.
Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
International Journal of Radiation Oncology Biol Phys 1999; 44: 607-618
49. Stadler R.
Bildatlas Malignes Melanom
Deutscher Universitäts-Verlag, 2000
50. Storm EA, Ross MI.
Adjuvant radiation therapy after axillary lymphadenectomy for metastatic melanoma:
toxicity and local control.
Annals of Surgical Oncology 1995; 5: 445-449
51. Trott Kr, von Lieven H, Kummermehr J, et al.
The radiosensitivity of malignant melanomas, part 1: experimental studies.
International Journal of Radiation Oncology Biol Phys 1981; 7: 9-13
52. Trott Kr, von Lieven H, Kummermehr J, et al.
The radiosensitivity of malignant melanomas, part 2: clinical studies.
International Journal of Radiation Oncology Biol Phys 1981; 7: 15-20
53. Veronesi U, Adamus J, Bandiera DC, et al.
Inefficacy of immediate node dissection in stage I melanoma of the limbs.
New England Journal of Medicine 1977; 297: 627-630
Lebenslauf
PERSÖNLICHE DATEN
Name Margot Hanna Debiec Geburtsdatum 29.12.1975
Geburtsort Gleiwitz (Polen) Familienstand ledig
Konfession katholisch
SCHULBILDUNG
1982-1989 Grundschule Nr. 9 (Jana 3. Sobieskiego) in Gleiwitz
1989-1991 Konrad Adenauer Schule, Fulda
1991-1995 Freiherr vom Stein Gymnasium, Fulda 1995 Abitur
HOCHSCHULBILDUNG
10/1995-... Beginn des Medizinstudiums an der Justus-Liebig-Universität Gießen